Lucy Young is an Ophthalmology physician affiliated with Massachusetts Eye and Ear Infirmary. OpenAlex indexes 193 publications with 5,818 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St Meei
Massachusetts Eye And Ear Infirmary
Boston, MA 021143002
Telephone
617-573-3710Registry record last updated 14 Oct 2009.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alimera Sciences, Inc.Program year20231 payment
- Genentech USA, Inc.Program year20231 payment
- Alcon Vision LLCProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
63.6%Corticosteroid63.6%Prednisolone Acetate100%Part D≥12 patientsMusculoskeletal
36.4%Nonsteroidal Anti-inflammatory Drug36.4%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1988–1998 per NIH RePORTER. The latest:
- OCULAR MELANOMA--DEVELOPMENT OF A PHOTODYNAMIC THERAPY
Massachusetts Eye and Ear Infirmary
FY1998R29EY010975 - OCULAR MELANOMA--DEVELOPMENT OF A PHOTODYNAMIC THERAPY
Massachusetts Eye and Ear Infirmary
FY1997R29EY010975 - OCULAR MELANOMA--DEVELOPMENT OF A PHOTODYNAMIC THERAPY
Massachusetts Eye and Ear Infirmary
FY1996R29EY010975
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina
Proceedings of the National Academy of Sciences
2019
Similar KOLs
Other experts from the same institution or the same specialty.
John Kempen, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Demetrios Vavvas, MD, PhD
Massachusetts Eye and Ear Infirmary
Evangelos Gragoudas, MD
Massachusetts Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”